ZAQS.ORG

Estrogen patches are hard to find, and it may not be resolved any time soon

12 hours ago

Chan Zuckerberg Initiative's Biohub to open new rare disease funding round

1 day ago

This life sciences stock has a secret weapon, and AI will only make it more valuable

2 days ago

Extreme heat grips Europe as red alerts issued in UK, France, Spain and Italy

2 days ago

UPS to invest $48 million in cold facilities amid GLP-1 boom

3 days ago

SNAP restrictions could change what shoppers buy — and food giants are watching

6 days ago

U.S. opens tariff probe targeting Germany's drug pricing policies

7 days ago

What this biotech's volatile stock price tells you about the weight loss market right now

7 days ago

UniQure to seek FDA approval for Huntington's disease gene therapy in reversal

7 days ago

Biotech IPO revival faces competition from cash-rich big pharma buyers

10 days ago

Centene to offer buyouts to some employees as health insurer cuts costs

11 days ago

Drugmakers race to find a place in the next wave of obesity drugs

13 days ago

CVS Health executives on reducing healthcare's biggest pain points

13 days ago

Rollins called screwworm a 'little pest' amid U.S. spread. Last year, she called it 'terrifying'

15 days ago

How screwworm in U.S. cattle herds could re-inflate record beef prices

16 days ago

The space race is coming for pharma: Why drug development is heading to orbit

16 days ago

Nuvalent shares surge 39% after GSK agrees to buy drugmaker for $10.6 billion

17 days ago

Jim Cramer says he can't sell Eli Lilly despite its massive run up. Here's why

18 days ago

GLP-1 pioneers Novo and Lilly compete on pills, prepare to pitch seniors

18 days ago

Food supply 'not at risk' after new Texas screwworm cases, USDA secretary says

18 days ago

Weight loss drug maker sinks 23% after new safety data spooks investors

18 days ago

U.S. confirms second Texas screwworm case, Canada restricts livestock imports

20 days ago

AstraZeneca CEO says AI is reshaping drug development — and helping boost the odds of success

21 days ago

Warren Buffett disciple Guy Spier's rare cancer changed how he values everything

21 days ago

An 'EpiPen' for heart attacks?: The market has yet to give this drug stock credit

21 days ago

As the World Cup kicks off, health officials are focused on more than Ebola

22 days ago

'Buying stuff like it's going out of fashion': Biotech M&A on track for best year since pre-Covid

22 days ago

Eli Lilly's top dealmaker says don't be surprised to see more M&A

22 days ago

Biotech Abivax sinks 43% as cancer cases cloud trial data for bowel disease drug

17 days ago

Lung cancer drug from Akeso, Summit cut risk of death by 34% in late-stage trial

24 days ago

Why Trump reversed course to fast-track psychedelic drugs for mental healthcare

26 days ago

Replimune to resubmit twice rejected drug for approval after FDA shakeup

26 days ago